Sebastian Kobold

University Hospital

Research Interests

Explore related searches

Contact this professor

Google Scholar

Articles (21)

Collaborators (11)

Johannes vom Berg

University of Zurich

Roland Kappler

LMU University Hospital

Maries van den Broek

University of Zurich

Anne Jouinot

Institut Cochin

Alan Graham Pockley

Emeritus Professor of Immunobiology

University of Nottingham

UNITED KINGDOM

Matthias Justus Nikolaus Seifert

National Cancer Institute

UNITED STATES

Lars König

University Hospital, LMU Munich

Georgios T. Stathopoulos

University of Patras

Nadia El Khawanky

Technical University of Munich

Lea Huber-Hürlimann

Nardine Soliman

Technical University of Munich

Sebastian Kobold

Research Interests

Explore related searches

Contact this professor

Articles (21)

Collaborators (11)

Johannes vom Berg

Roland Kappler

Maries van den Broek

Anne Jouinot

Alan Graham Pockley

Matthias Justus Nikolaus Seifert

Lars König

Georgios T. Stathopoulos

Nadia El Khawanky

Lea Huber-Hürlimann

Nardine Soliman

How do I reach out?

Meet Kite AI

Sebastian Kobold

Research Interests

Explore related searches

Contact this professor

Articles (21)

Targeting Intracellular Innate RNA-Sensing Systems Overcomes Resistance to CAR T-cell Therapy in Solid Tumors

Metabolites as agents and targets for cancer immunotherapy

Long-term consequences of cancer therapy: cognitive impairment following CAR T cell therapy

Predictive value of preclinical models for CAR-T cell therapy clinical trials: a systematic review and meta-analysis

Steroid hormones as modulators of anti-tumoural immunity

The role of single cell transcriptomics for efficacy and toxicity profiling of chimeric antigen receptor (CAR) T cell therapies

Flycodes enable simultaneous preclinical analysis for dozens of antibodies in single cassette–dosed mice

RORing CAR T Cells in Solid and Hematologic Cancers: Same but Different

STING activation improves T-cell-engaging immunotherapy for acute myeloid leukemia.

Prognostic significance of immune reconstitution following CD19 CAR T-cell therapy for relapsed/refractory B-cell lymphoma.

CAR T cells for solid tumors – developments to watch in 2023

Role and Potential of Different T Helper Cell Subsets in Adoptive Cell Therapy

An In Vivo Inflammatory Loop Potentiates KRAS Blockade

Migratory Engineering of T Cells for Cancer Therapy

Enhanced Chimeric Antigen Receptor T Cell Therapy through Co-Application of Synergistic Combination Partners

NK Cells Armed with Chimeric Antigen Receptors (CAR): Roadblocks to Successful Development

Attenuation of peripheral serotonin inhibits tumor growth and enhances immune checkpoint blockade therapy in murine tumor models

T cells armed with C-X-C chemokine receptor type 6 enhance adoptive cell therapy for pancreatic tumours

The Neurokinin-1 Receptor Is a Target in Pediatric Rhabdoid Tumors

Alterations in regulatory T cells and immune checkpoint molecules in pancreatic cancer patients receiving FOLFIRINOX or gemcitabine plus nab-paclitaxel

Paralysis of the cytotoxic granule machinery is a new cancer immune evasion mechanism mediated by chitinase 3-like-1

Collaborators (11)

Johannes vom Berg

Roland Kappler

Maries van den Broek

Anne Jouinot

Alan Graham Pockley

Matthias Justus Nikolaus Seifert

Lars König

Georgios T. Stathopoulos

Nadia El Khawanky

Lea Huber-Hürlimann

Nardine Soliman

How do I reach out?

Meet Kite AI